Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX By Ogkologos - March 11, 2025 585 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source RELATED ARTICLESMORE FROM AUTHOR Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides Protection Against HPV16 or HPV18 Infection and Is Not Inferior To Two Doses MOST POPULAR Leveraging Extensive Real-World Data to Systematically Identify Mutations that Predict the... July 11, 2022 Artificial Intelligence Expedites Brain Tumor Diagnosis during Surgery February 12, 2020 Finding Purpose in Sharing Your Story: A Q&A With Esophageal Cancer... January 5, 2023 When Both Tumour-Infiltrating Lymphocytes and Gene Expression are Available, the Prognostic... January 23, 2023 Load more HOT NEWS Efficacy of Sunitinib in Patients with Metastatic Phaeochromocytomas and Paragangliomas SBRT Emerging as an Important Treatment for Early-Stage Kidney Cancer FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular... Cannabis, cannabinoids and cancer – the evidence so far
